PATENT CLAIM ANALYSIS

Application Number: 15756342
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "295000"]

Abstract:
Provided are a conjugate of memantine and arctigenin, and a pharmaceutical composition comprising the conjugate. The conjugate can treat diseases associated with Aβ or Tau protein pathways, such as Alzheimer's disease or Parkinson's disease.

Claim (Index 10):
The method according to  claim 8 , further comprising administering to a subject in need thereof an additional agent for the treatment of a disease associated with the A\u03b2 or Tau protein pathway.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13063525', '16084979', '13940016', '15552556', '13442244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7370469025185502
- 35 USC 102 Novelty (BERT): 0.4947912899882293
- Combined Prediction Score: 0.7128213412655181
- Mean Citation Score: 207.164244
- Max Citation Score: 211.74594
- Similarity Product: 143.93969725105762

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test